C07D 417 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group

Patents for C07D 417 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group (62,773)
11/2004
11/17/2004	EP1210333B1 p-Tolyl-heterocycles as herbicides
11/17/2004	EP1082321B1 Heterocyclic derivatives which inhibit factor xa
11/17/2004	CN1547672A Ultrasonic doppler effect speed measurement
11/17/2004	CN1547580A CCR5 antagonists useful for treating aids
11/17/2004	CN1547579A 4-(phenyl-piperdin-4-ylidene-methyl)-benzamide derivatives and their use for the treatment of pain, anxiety or gastrointestinal disorders
11/17/2004	CN1547574A Novel 2,4-diaminothiazole derivatives
11/17/2004	CN1546472A Pyridyl alkane acid amides as cytostatics and immunosupressives
11/17/2004	CN1546470A 6-phenylpyridyl-2-amine derivatives
11/17/2004	CN1176066C 1,1-and 1,2-disubsitituted cyclopropane compounds, preparation method thereof and drug compositions containing the same
11/16/2004	US6818663 As inhibitors of cyclin-dependent kinase 4 (cdk4); antiproliferative agents; for therapy of cancer, tumors
11/16/2004	US6818658 Treating obesity, diabetes, sexual dysfunction, including erectile dysfunction and female sexual dysfunction.
11/16/2004	US6818645 2-amino-trihydroindole or tetrahydronapthalene-2-yl derivatives, useful for disease state associated with smooth muscle disorders, such as gastrointestinal and urogenital disorders
11/16/2004	US6818640 2-imino-1,3-thiazine derivatives
11/16/2004	US6818262 Squarylium dyes
11/16/2004	CA2247164C Oxa- and thia-diazole muscarinic receptor antagonists
11/11/2004	WO2004096798A2 Derivatives of 2-acylamino-4-phenylthiazole, preparation method thereof and use of same as chemokine antagonists
11/11/2004	WO2004096797A1 Inhibitors of phosphatidylinositol 3-kinase
11/11/2004	WO2004096784A1 New heterocyclic amides exhibiting an inhibitory activity at the vanilloid receptor 1 (vr1).
11/11/2004	WO2004096781A1 Use of derivatives of 2, 4-dihydro-[1,2,4]triazole-3-thione as inhibitors o fteh enzyme myeloperoxidase (mpo)
11/11/2004	WO2004096774A1 Acyl isoindoline derivatives and acyl isoquinoline derivatives as anti-viral agents
11/11/2004	WO2004096768A1 Anti-diabetic agents
11/11/2004	WO2004096220A1 8-(3-biaryl)phenylquinoline phosphodiesterase-4-inhibitors
11/11/2004	WO2004096210A1 Acylated indoline and tetrahydroquinoline derivatives as hcv inhibitors
11/11/2004	WO2004096135A2 Inhibitors of akt activity
11/11/2004	WO2004096131A2 Inhibitors of akt activity
11/11/2004	WO2004096129A2 Inhibitors of akt activity
11/11/2004	WO2004087690A3 Benzimidazole derivatives and their use for modulating the gaba-a receptor complex
11/11/2004	WO2004087053A9 Dipeptidyl peptidase inhibitors
11/11/2004	WO2004078748A3 Novel bicyclic urea derivatives useful in the treatment of cancer and other disorders
11/11/2004	WO2004072052A3 Isoxasole-containing thiourea inhibitors useful for treatment of varicella zoster virus
11/11/2004	WO2004026844A9 Methods and compositions of novel triazine compounds
11/11/2004	WO2003079973A3 Mitotic kinesin inhibitors
11/11/2004	US20040225111 Therapy for osteoporosis
11/11/2004	US20040224997 Preparation and use of aryl alkyl acid derivatives for the treatment of obesity
11/11/2004	US20040224996 Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
11/11/2004	US20040224986 Piperidinyl targeting compounds that selectively bind integrins
11/11/2004	US20040224983 Cholecystokinin receptors as modulators to mediate diseases and gastrointestinal disorders
11/11/2004	US20040224966 Enzyme inhibitors as drugs for cardiovascular disorders, aids, alzheimers disease or urogenital disorders
11/11/2004	US20040224960 Pharmaceutical compositions and methods for their use
11/11/2004	US20040224955 Viral polymerase inhibitors
11/11/2004	US20040224953 Fused bicyclic-substituted amines as histamine-3 receptor ligands
11/11/2004	US20040224952 e.g., 4-{2-[2-(2-(R)-Methyl-pyrrolidin-1-yl)-ethyl]-benzothiazol-5-yl}-benzonitrile; useful for treating conditions and disorders related to memory and cognition processes, neurological processes, cardiovascular function, and body weight.
11/11/2004	US20040224950 e.g., N-Cycloheptyl-N'(1-ethyl-pyrrolidin-2-ylmethyl)-6-(3-fluoro-4-methoxy-phenoxy)-[1,3,5]triazine-2,4-diamine; treating unwanted cellular proliferation, an inflammation mediated disease, or a hyperproliferative disease, or modulating a glycosidase enzyme
11/11/2004	US20040224944 Pyrazole compounds useful as protein kinase inhibitors
11/11/2004	US20040224875 Inhibitors of glutaminyl cyclase
11/11/2004	US20040223912 Compositions and methods for non-invasive imaging of soluble beta-amyloid
11/11/2004	US20040223909 Compositions and methods for non-invasive imaging of soluble beta-amyloid
11/11/2004	CA2523336A1 8-(3-biaryl)phenylquinoline phosphodiesterase-4-inhibitors
11/11/2004	CA2523102A1 Substituted indoline and indole derivatives
11/11/2004	CA2523020A1 Use of derivatives of 2, 4-dihydro-[1,2,4]triazole-3-thione as inhibitors of the enzyme myeloperoxidase (mpo)
11/11/2004	CA2522431A1 Inhibitors of akt activity
11/11/2004	CA2522262A1 Inhibitors of akt activity
11/11/2004	CA2521962A1 Anti-diabetic agents
11/11/2004	CA2521158A1 Derivatives of 2-acylamino-4-phenylthiazole, preparation method thereof and application of same in therapeutics
11/10/2004	EP1475378A1 Antidiabetic thiazolidinedione potassium salt
11/10/2004	EP1475377A1 Derivatives of indole and their use as phosphodiesterase 4 inhibitors
11/10/2004	EP1475374A1 Thiadiazole compounds and use thereof
11/10/2004	EP1475371A1 1-substituted-1-aminomethyl-cycloalkane derivatives (= gabapentin analogues), their preparation and their use in the treatment of neurological disorders
11/10/2004	EP1474423A1 Heterocyclic tripeptides as hepatitis c inhibitors
11/10/2004	EP1474421A1 Imidazole 4-carboxamide compounds with adenosine deaminase inhibiting activity
11/10/2004	EP1474418A1 Substituted 4-hetaryl-pyrazolines as pest control agents
11/10/2004	EP1474415A1 1-phenyl-2-heteroaryl-substituted benzimidazole derivatives, the use thereof for producing drugs used in the treatment of immunological diseases
11/10/2004	EP1474398A1 N-allyloxyethyl-1,2,3,4,5,6-hexahydro-2,6-methano-3-benzazocines and the use of the same as pharmaceuticals
11/10/2004	EP1474395A1 Nicotinamide derivates useful as p38 inhibitors
11/10/2004	EP1474389A2 Delta1-pyrrolines
11/10/2004	EP1474147A1 Pyrimidine-based compounds useful as gsk-3 inhibitors
11/10/2004	EP1474137A1 Use of indole-3-acetic acids in the treatment of asthma, copd and other diseases
11/10/2004	EP1161423B1 Thiazolyl urea derivatives and their utilization as antiviral agents
11/10/2004	CN1545700A Optical data carrier that contains a cationic aminoheterocyclic dye as the light-absorbing compound in the information layer
11/10/2004	CN1545514A Production method for beta type crystal anhydrous ammonia leaven
11/10/2004	CN1545508A 1,2,4-trioxolane antimalarials
11/10/2004	CN1545411A Cyclopropyl and cyclobutyl epothilone analogs
11/10/2004	CN1544420A Inhibition of raf kinase using substituted heterocyclic ureas
11/10/2004	CN1174978C Heterocyclic compound as inhibitors of rotamase enzymes
11/09/2004	US6815547 Quinolylpropylpiperidine derivatives, their preparation, and compositions containing them
11/09/2004	US6815460 Process for preparing prodrugs of benzenesulfonamide-containing cox-2 inhibitors
11/09/2004	US6815458 Nervous system disorders
11/09/2004	US6815457 5-(4-(2-(n-methyl-n-(2-pyridyl)amino)ethoxy)benzyl)thiazolidin e-2,4-dione, maleic acid salt in polymorphic form
11/09/2004	US6815445 Substituted diphenyloxazoles, the synthesis thereof, and the use thereof as fluorescence probes
11/09/2004	US6815440 For therapy and prophylaxis of disorders in the course of which is involved an increased activity of matrix-degrading metalloproteinases
11/04/2004	WO2004094395A2 Biaryl substituted thiazoles, oxazoles and imidazoles as sodium channel blockers
11/04/2004	WO2004094394A1 Benzisothiazol-3-one-carboxylic acid amides as phospholipase inhibitors
11/04/2004	WO2004094388A2 Indazole derivatives as jnk inhibitors
11/04/2004	WO2004094375A2 4 - (3,4 - disubstituted phenyl) - pyrrolidin-2-one compounds as phosphodiesterase 4 inhibitors
11/04/2004	WO2004093880A1 4-anilino-quinazoline derivatives as antiproliferative agents
11/04/2004	WO2004093817A2 Chemokine receptor binding heterocyclic compounds with enhanced efficacy
11/04/2004	WO2004093789A2 Use of galr3 receptor antagonists for the treatment of depression and/or anxiety and compounds useful in such methods
11/04/2004	WO2004078747A8 Novel cyanopyridine derivatives useful in the treatment of cancer and other disorders
11/04/2004	WO2004067506A3 Substituted heterocyclic compounds
11/04/2004	WO2004062613A3 Hiv integrase inhibitors
11/04/2004	WO2004061084A3 Modulation of protein functionalities
11/04/2004	WO2004060865A3 N-(substituted arylmethyl)-4-(disubstituted methyl)piperidines and piperazines
11/04/2004	WO2004056774A3 Substituted biphenyl-4-carboxylic acid arylamide analogues as capsaicin receptor modulators
11/04/2004	WO2004024059A3 Improved process for preparation of thiazolidinedione derivatives
11/04/2004	WO2003087044A3 Novel carboxamide compounds for use in mch receptor related disorders
11/04/2004	US20040220244 PHOSPHOLIPASE INHIBITORS; use of inhibitor compositions in mammals to relieve sick conditions accompanied by enhanced PLA(2) activity such as inflammation, asthma, rhinitis, bronchitis, pneumonia, adult respiratory distress syndrome, inflammatory intestine disorder, Crohn's disease
11/04/2004	US20040220243 optionally substituted thiazolyl, oxazolyl or pyrazolyl substituted heterocycles; use as pesticides and herbicides
11/04/2004	US20040220233 for treating p38 kinase-associated conditions; may be useful in treating inflammatory bowel disease, rheumatoid arthritis, psoriasis, multiple sclerosis, endotoxin shock, osteoporosis, Alzheimer's disease, and congestive heart failure
11/04/2004	US20040220232 Organometallic reagent reacted with an activated carboxylic acid to produce a ketone which is reacted with carbon disulfide and dihalomethane, further reacting the dithietane product with a secondary amine, and condensing the thioamide with hydrazine; useful as p38 kinase and COX-2 inhibitors
11/04/2004	US20040220230 transfroming growth factor antagonist; therapy for urogenital disorders, cardiovascular disorders

1 ... 336 337 338 339 340 341 342 343 344 345 346 347 348 349 350 351 352 353 354 355 356 ... 628